Menu
Search
|

Menu

Close
X

PRA Health Sciences Inc PRAH.OQ (NASDAQ Stock Exchange Global Select Market)

88.90 USD
-0.27 (-0.30%)
As of Feb 16
chart
Previous Close 89.17
Open 88.92
Volume 127,308
3m Avg Volume 162,993
Today’s High 89.64
Today’s Low 88.73
52 Week High 95.47
52 Week Low 57.73
Shares Outstanding (mil) 62.65
Market Capitalization (mil) 5,000.23
Forward P/E 51.89
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.77 Mean rating from 13 analysts

KEY STATS

Revenue (mm, USD)
FY17
1,021
FY16
1,812
FY15
1,614
EPS (USD)
FY17
0.835
FY16
1.038
FY15
1.292
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
51.89
32.90
Price to Sales (TTM)
vs sector
2.57
5.77
Price to Book (MRQ)
vs sector
5.93
5.41
Price to Cash Flow (TTM)
vs sector
30.03
23.42
Total Debt to Equity (MRQ)
vs sector
98.90
16.52
LT Debt to Equity (MRQ)
vs sector
94.27
12.22
Return on Investment (TTM)
vs sector
5.82
14.43
Return on Equity (TTM)
vs sector
12.88
16.13

EXECUTIVE LEADERSHIP

Colin Shannon
Chairman of the Board, President, Chief Executive Officer, Since 2014
Salary: $746,500.00
Bonus: $345,000.00
Linda Baddour
Chief Financial Officer, Executive Vice President, Since 2014
Salary: $436,000.00
Bonus: $150,000.00
David Dockhorn
Executive Vice President, Corporate Compliance Officer, Since 2014
Salary: $377,900.00
Bonus: $100,000.00
Max Lin
Director, Since 2014
Salary: --
Bonus: --
James Momtazee
Director, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

4130 Parklake Ave Ste 400
RALEIGH   NC   27612-4462

Phone: +1919.7868200

PRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.

SPONSORED STORIES